A Study to Evaluate the Efficacy of MEDI7510 in Older Adults
Public ClinicalTrials.gov record NCT02508194. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Randomized, Double-blind Study to Evaluate the Efficacy of MEDI7510 for the Prevention of Acute Respiratory Syncytial Virus-associated Respiratory Illness in Older Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will be the first assessment of the efficacy of MEDI7510 for the prevention of respiratory syncytial virus (RSV) disease. It will also provide estimates of vaccine efficacy and of endpoint incidence in the placebo arm. It will also assess the safety and immunogenicity of concurrent dosing of MEDI7510 and IIV to expand on the observations made in the Phase 1b study of MEDI7510. It will also expand the safety database of participants dosed with MEDI7510. The study will also assess the immune response to MEDI7510 in Season 1 and Season 2.
Study identification
- NCT ID
- NCT02508194
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1,900 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 29, 2015 (Actual)
- Primary completion
- Sep 9, 2016 (Actual)
- Completion
- Nov 7, 2016 (Actual)
- Last update posted
- Dec 26, 2017
2015 – 2016
United States locations
- U.S. sites
- 30
- U.S. states
- 16
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Sacramento | California | 95864 | — |
| Research Site | San Francisco | California | 94108 | — |
| Research Site | Aurora | Colorado | 80045 | — |
| Research Site | Littleton | Colorado | 80127 | — |
| Research Site | Lady Lake | Florida | 32159 | — |
| Research Site | Miami | Florida | 33143 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Savannah | Georgia | 31406 | — |
| Research Site | Champaign | Illinois | 61820 | — |
| Research Site | Chicago | Illinois | 60654 | — |
| Research Site | Council Bluffs | Iowa | 51503 | — |
| Research Site | Augusta | Kansas | 67010 | — |
| Research Site | Wichita | Kansas | 67205 | — |
| Research Site | Edina | Minnesota | 55435 | — |
| Research Site | Cincinnati | Missouri | 45249 | — |
| Research Site | Kansas City | Missouri | 64114 | — |
| Research Site | Bellevue | Nebraska | 68005 | — |
| Research Site | Norfolk | Nebraska | 68701 | — |
| Research Site | Omaha | Nebraska | 68134 | — |
| Research Site | Rochester | New York | 14621 | — |
| Research Site | Charlotte | North Carolina | 28209 | — |
| Research Site | Hickory | North Carolina | 28602 | — |
| Research Site | Raleigh | North Carolina | 27609 | — |
| Research Site | Rocky Mount | North Carolina | 27804 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Akron | Ohio | 44311 | — |
| Research Site | Dakota Dunes | South Dakota | 57049 | — |
| Research Site | Knoxville | Tennessee | 37912 | — |
| Research Site | Nashville | Tennessee | 37212 | — |
| Research Site | Murray | Utah | 84123 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02508194, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 26, 2017 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02508194 live on ClinicalTrials.gov.